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 Integrin-linked kinase (ILK) is a serine-threonine kinase
that binds to the cytoplasmic tails of β1- and β3-integrins (re-
viewed in [1]). It acts as an intermediate signaling protein
during apoptosis/stress induction [2,3], differentiation [4,5],
proliferation [6,7], and cellular interaction with the extracel-
lular matrix (ECM) [8,9]. ILK has been shown to act down-
stream and independently of the phosphatidylinositol-3-kinase
(PI3K) pathway to phosphorylate target proteins such as β1/
β3-integrins, protein kinase B (Akt), and glycogen synthase
kinase-3β (GSK-3β) [1]. Although significant publications
have appeared describing the role of ILK in many tissues, in
cancer biology (reviewed in [10]), and in several developmen-
tal systems, few studies have been conducted in the mamma-
lian eye. It has been speculated that ILK is important in the
lens because the motility, differentiation, ECM interaction, and
survival of lens epithelia are required for lens development
and function. It has also been suggested that, subsequent to
cataract surgery, ILK could play a role in the requisite epithe-
lial-mesenchymal-transition (EMT) of LEC, which contrib-
utes to the development of posterior capsular opacification
(PCO) [11]. Consistent with this proposal, ILK has been iden-
tified as a regulator of EMT progression in several epithelia,
e.g., renal and ovarian [12-14].
The majority of work on ILK has been performed with
several commercially-available antibodies; the most com-
monly-used reagents are a mouse monoclonal antibody and
rabbit polyclonal antibodies (Upstate Signaling, Lake Placid,
NY). These antibodies appear to recognize alternate forms of
ILK of 50 kDa and 60 kDa on immunoblots of cellular ly-
sates. Despite these differences, the polyclonal antibody has
been used for immunoprecipitation and subsequent ILK ac-
tivity assays in the majority of recent studies. Neither of the
antibodies has been used to show localization of ILK by stain-
ing of lens tissue.
To characterize ILK within the lens and its role in LEC
EMT, we developed an affinity-purified, polyclonal antibody
which recognizes both human and murine ILK by immuno-
precipitation, immunohistochemistry, immunocytochemistry,
and immunoblotting. With this antibody (R3B1) we determined
the expression levels and localization of ILK within the mu-
rine lens. Furthermore, using ILK-targeting short interfering
RNA (siRNA), we have shown that ILK is an important factor
in the EMT of murine LEC, grown from lens explants.
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Purpose: To evaluate the expression and location of integrin-linked kinase (ILK) within the mouse lens and to character-
ize the role of this protein during mouse lens epithelial cells (LEC) differentiation in vitro.
Methods: Transcription levels of ILK mRNA were determined by RT-PCR in cultured cells and lens tissue. ILK protein
was detected by immunoblotting, immunocytochemistry, immunohistochemistry, and immunoprecipitation. A role for
ILK in the outgrowth of LEC from dissected mouse lens explants was determined by the use of ILK short interfering RNA
(siRNA). Affinity-purified polyclonal anti-recombinant human ILK IgG was prepared and characterized for these experi-
ments. A comparison of several anti-ILK antibodies was performed by immunoblotting, immunoprecipitation, and ELISA.
Results: ILK was transcribed in LEC and lens fiber cells in vivo. ILK protein was expressed in the differentiating LEC at
the equatorial region of the lens and, to a lesser extent, within the cortical and nuclear fiber cells. LEC in vitro produced
copious ILK, which exhibited a filamentous pattern throughout the cytoplasm. The expression of ILK was increased
during epithelial-mesenchymal-transition (EMT) of LEC from lens explants, whereas inhibition of ILK by siRNA de-
layed expression of the EMT markers smooth muscle α-actin and fibronectin.
Conclusions: Analysis of ILK expression, localization, and activity in the mouse lens and cultured LEC is substantially
facilitated by the generation of a multi-functional, polyclonal, affinity-purified anti-ILK antibody. Expressed in most
tissues and cells lines, ILK is unexpectedly restricted to the equatorial LEC and differentiated fiber cells of the mouse lens.
The occurrence of ILK expression with LEC differentiation is consistent with the positive regulatory function of ILK,
which is revealed in a model of EMT in vitro. This is the first study to show the expression of ILK in the lens and its unique
distribution pattern within cultured lens epithelia.
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METHODS
Animals:  All experiments were conducted in accordance with
the ARVO Statement for the Use of Animals in Ophthalmic
and Vision Research, and were carried out with the written
permission of the relevant local institutional authorities.
Antibodies:  For immunoblotting, immunoprecipitation,
and staining procedures, the following antibodies were used:
monoclonal anti-α-smooth muscle actin (α-SMA; Sigma, St.
Louis, MO), monoclonal anti-ILK (Upstate), rabbit polyclonal
anti-ILK (Upstate), mouse anti-VLA-5 (α5β1) integrin
(Chemicon, Temecula, CA), hamster anti-β1 integrin (Santa
Cruz Biotechnology, Santa Cruz, CA), mouse anti-glyceral-
dehyde 3-phosphate dehydrogenase (GAPDH; Ambion Inc.,
Austin, TX), goat anti-early endosome-associated protein 1
(EEA1; Santa Cruz Biotechnology), monoclonal anti-cellular
fibronectin (Sigma), and monoclonal anti-phospho-myelin
basic protein (MBP, HRP-conjugate; Upstate).
Production and affinity-purification of polyclonal anti-
ILK antibodies:  Rabbits were injected with the intact 50 kDa
recombinant human (rh) ILK protein which was expressed in
Escherichia coli BL21-Rosetta strain (Novagen, Madison, WI)
and purified in our laboratory. The antibodies were purified
by affinity chromatography on a column with the antigen
coupled to CNBr-activated Sepharose (Amersham Bio-
sciences, Piscataway, NJ). Anti-ILK IgG (preparation R3B1)
was used for the studies reported herein.
Specificity of affinity-purified antibodies was determined
by immunoblot (as detailed below) against 500 ng of rhILK.
ELISAs were also performed with rhILK. Briefly, graduated
concentrations of rhILK were incubated in 96-well ELISA
plates overnight at 4 °C. Plates were washed with buffer (Hanks
Buffered Salt Solution [HBSS], 0.05% Tween-20)and blocked
(HBSS, 0.1% Tween-20, and 5% casein acid hydrolysate) at
room temperature for 2 h. Primary antibodies (affinity-puri-
fied, commercial monoclonal, and commercial polyclonal)
were incubated with rhILK at 1 mg/ml for 2 h at room tem-
perature. After washing, 1:5000 dilution of a secondary anti-
body (donkey anti-rabbit-horseradish peroxidase; Jackson
ImmunoResearch Laboratories,Inc., West Grove, PA) was in-
cubated at room temperature for 1 h. Plates were washed and
incubated with peroxidase substrate (3.3',5.5'-
tetramethylbenzidine; Pierce, Rockford, IL). Reactions were
stopped with 10% H3PO4 and absorbance was read at 450 nm
minus 650 nm on a Maxisorp 96-well ELISA plate reader
(Nalge Nunc, Rochester, NY). Immunoprecipitations from
LEC lysates were performed (as detailed below) with affin-
ity-purified and commercially-available polyclonal antibod-
ies, and subsequent immunoblots were probed with mono-
clonal anti-ILK antibody. Antibodies were routinely used at 1
µg/ml for immunoblotting and 10 µg/ml for immunofluores-
cence.
Cell culture:  C57Bl6/J x 129/SVJ mouse LEC were cul-
tured from lens epithelial explants (described previously)
[15,16]. Cells were maintained in Dulbecco’s modified Eagle’s
medium (DMEM; Invitrogen, Carlsbad, CA) supplemented
with 10% fetal bovine serum (FBS; Invitrogen), 100 U/ml
penicillin G, and 100 µg/ml streptomycin SO4 at 37 °C in a
humidified atmosphere containing 5% CO2. For long-term
culture, cells were subcultured in 10% FBS/DMEM and were
subcultured at a ratio of 1:3. A human lens epithelial cell line
(SRA 01/04, provided by Dr. Venkat Reddy, Kellogg Eye Cen-
ter, Ann Arbor, MI) was maintained in 10% FBS/DMEM. A
human retinal pigment epithelial cell line (hRPE, ARPE-19,
purchased from the ATCC) was maintained in a 1:1 mixture
of DMEM and Ham’s 12 media containing 20% FBS, 56 mM
sodium bicarbonate, and 2 mM L-glutamine.
Immunoblotting:  Cultured cells were kept either in nor-
mal growth media or in serum-free media containing 1% BSA
for 48 h to induce stress. Dissected tissues or cultured cells
were subsequently lysed with ILK-lysis buffer (1% NP40, 50
mM Hepes, 150 mM NaCl, 5 mM Na3VO4, 5 mM NaF, and
DNAse, 400 µg/ml) containing protease inhibitors (Pierce).
Proteins were subjected to SDS-PAGE on 12% acrylamide
gels. All blots were probed with anti-ILK IgG, anti-GAPDH,
and in the case of the cultured cells, anti-αSMA antibodies.
All primary antibody incubations were followed by an appro-
priate horseradish peroxidase-coupled secondary antibody
(Jackson ImmunoResearch Laboratories, Inc.). The complex
was detected by chemiluminescence (Supersignal West Pico
reagents; Pierce).
RT-PCR:  Total RNA was isolated from lens epithelia and
fiber cells of either 1-month-old C57Bl6/J x 129/SVJ mice or
from cultured LEC, with the RNeasy Mini Kit (Qiagen,
Valencia, CA; described previously) [17]. One µg of RNA was
reverse-transcribed into cDNA with the Omniscript RT Kit
(Qiagen). cDNA was amplified by use of the following primer
pairs: ILK, For 5'-TTT TCA CTC AGT GCC GGG AGG-3',
Rev 5'-GTG CCT TGG CTT TGT CCA CAG-3'; GAPDH,
For 5'-GAC CCC TTC ATT GAC CTC AAC T-3', Rev 5'-
GTT TGT GAT GGG TGT GAA CCA-3'. The PCR program
was 12 min at 94 °C, followed by cycles of 45 s at 95 °C, 59 s
at 65 °C, and 2 min at 72 °C, followed by a final extension of
8 min at 72 °C. GAPDH was used as an internal control for
normalization to a reference standard. PCR products were sepa-
rated on 2% agarose gels and were visualized by staining with
ethidium bromide.
Immunohistochemistry:  Eyeballs from C57Bl6/J x 129/
SVJ 1-month-old mice [18] were fixed in 3.7% paraformalde-
hyde for 4 h at room temperature or were frozen directly at -
80 °C in OCT compound (Sakura, Torrance, CA). Paraform-
aldehyde-fixed eyeballs were dehydrated in a series of etha-
nol solutions and were embedded in paraffin. Sections were
subsequently deparaffinized and rehydrated. Antigen unmask-
ing was performed with Auto/Zyme (Biomeda, Foster City,
CA). Frozen eyeballs were sectioned on a cryostat at 6-8 µ.
These frozen sections were then warmed to room tempera-
ture, fixed in 4 °C acetone, and allowed to air-dry. Nonspe-
cific binding sites of all sections were blocked with 20%
Aquablock (East Coast Biologics Inc., North Berwick, MA)
in PBS-Tween (0.2%) for 1 h. Sections were subsequently in-
cubated with R3B1 anti-ILK antibody (10 µg/ml) for 2 h at
room temperature, washed in PBS-Tween, and exposed to goat
anti-rabbit IgG conjugated to FITC (Molecular Probes) for 1
h. All staining antibodies described above were used at con-
708centrations according to manufacturer’s protocols. Cell nu-
clei were stained with Hoechst 33258 fluorochrome (4 µg/ml;
Molecular Probes). Negative controls included replacement
of primary antibody by non-immune rabbit IgG, commercial
polyclonal anti-ILK (Upstate), or R3B1 preabsorbed overnight
at 4 °C with 10 µg/ml rhILK.
mRNA Silencing:  To decrease ILK expression during lens
epithelial outgrowth from mouse lens explants, we cultured
the explants (previously described) [15,16] with the follow-
ing modifications. Six µl of HiPerFect (Qiagen) was incubated
with either GFP-targeting siRNA (control) or an equimolar
mixture of 3 ILK-targeting siRNA constructs (#SI01076047,
#SI01076054, and #SI01076061; Qiagen) in serum-free
DMEM, according to the manufacturer’s protocol. Two mouse
lens explants for each sample were initially cultured in DMEM
containing 20% FBS and either a GFP- or an ILK-targeting
siRNA transfection mixture. The same siRNA mixtures were
added to cultures every 72 h for the duration of the explant
culture. At 7 and 14 days after the explants were started,
samples were processed as described above and were analyzed
by immunoblotting for EMT markers.
Immunocytochemistry:  Cells grown overnight on glass
coverslips in 10% FBS were washed with PBS and were sub-
sequently fixed with 3.7% formaldehyde in PBS. Coated cov-
erslips were incubated overnight at 4 °C with 10 µg/ml hu-
man plasma fibronectin (Calbiochem, La Jolla, CA). Staining
was performed with affinity-purified anti-ILK IgG ± an anti-
α5β1 integrin mouse IgG (10 µg/ml) or anti-β1 integrin ham-
ster IgG (10 µg/ml), followed by a fluorescein isothiocyanate
or tetramethylrhodamine isothiocyanate (FITC/TRITC)-con-
jugated goat anti-rabbit IgG, goat anti-mouse IgG, or goat anti-
hamster IgG, respectively (7.5 µg/ml; Jackson
ImmunoResearch Laboratories). Nuclei were stained with
Hoechst dye 33258 (4 µg/ml; Molecular Probes, Eugene, OR)
for 2 min. Cells were photographed with a Leica fluorescence
microscope (Leica Microsystems AG Wetzlar, Germany).
ILK immunoprecipitation and in vitro activity assay:  ILK
activity was determined as previously described, with minor
modifications [8]. After treatment, cells were lysed in ILK
lysis buffer. Lysates (250 µg) were incubated with 2 µg of one
of three products: commercial or affinity-purified rabbit anti-
©2007 Molecular Vision Molecular Vision 2007; 13:707-18 <http://www.molvis.org/molvis/v13/a76/>
Figure 1. Characterization of polyclonal ILK antibody.  A: Purified
rhILK used for antigen in rabbits. Lane 1, molecular weight stan-
dards; lane 2, 5 µg rhILK; lane 3, 10 µg rhILK. B: Immunoblot of
immortalized mouse LEC lysates probed with affinity-purified
polyclonal ILK IgG (R3B1; column 1), in comparison with commer-
cially-available anti-ILK monoclonal (column 2) and polyclonal an-
tibodies (column 3), before (-) and after (+) reduction with
dithiothreitol (DTT). C: ELISA showing binding of affinity-purified
anti-ILK IgG (R3B1) to rhILK (triangle) in comparison with com-
mercially-available anti-ILK polyclonal antibody (circle) and mono-
clonal antibodies (square). Each point represents three independent
experiments, ±SD. D: Comparison of ILK immunoprecipitated from
mouse LEC lysates with commercial and R3B1 IgG and subsequently
probed with commercial monoclonal antibody. Lane 1, rhILK; lane
2, lysate only (no antibody); lane 3, non-specific rabbit IgG; lane 4,
commercial polyclonal antibody; lane 5, R3B1. In A, B, and D, mo-
lecular weight markers are shown on the left of each panel.
709ILK polyclonal IgG (R3B1), non-specific rabbit IgG, or beads
alone, for 16 h at 4 °C with gentle agitation. Immune com-
plexes were purified through incubation with Protein A/G-
Sepharose (Santa Cruz Biotechnology) for 1 h at 4 °C, fol-
lowed by two sequential washes in ILK lysis buffer and two
sequential washes in ILK kinase buffer (50 mM HEPES, 10
mM MgCl2, 2 mM MnCl2, 5 mM Na3VO4, and 5 mM NaF).
Standard immunoprecipitation reactions were halted after 2
washes with ILK lysis buffer and were resolved by SDS-PAGE.
For ILK activity assays, the final wash was removed, and bead-
protein complexes were subsequently incubated with kinase
buffer, containing 200 mM ATP and 5 µg of MBP, at 30 °C for
25 min. Reactions were quenched with 2x SDS-PAGE sample
buffer containing 1 mM dithiothreitol (DTT) and were heated
at 90 °C for 10 min. Samples were resolved by SDS-PAGE,
transferred onto polyvinylidene difluoride-plus membranes
(Millipore, Billerica, MA), and immunoblotted with horse-
radish peroxidase-conjugated mouse anti-phospho-MBP
monoclonal antibody (Upstate).
RESULTS
Generation of a polyclonal anti-ILK antibody:  rhILK (about
50 kDa) was expressed in E. coli and was purified for use as
an antigen in rabbits (Figure 1A). Serum protein from injected
rabbits was affinity-purified and used for immunoblotting
against reduced and non-reduced rhILK; these results were
compared directly with those obtained with commercially-
available mouse monoclonal and rabbit polyclonal anti-ILK
reagents (Figure 1B). Affinity-purified R3B1 exhibited speci-
ficity similar to that of the monoclonal reagent, whereas the
commercial polyclonal antibody did not recognize the
nonreduced substrate and identified a band of alternate size
(about 60 kDa) within the reduced rhILK sample. Figure 1C
shows an ELISA comparing the three antibodies against in-
creasing concentrations of rhILK. Affinity-purified R3B1 ex-
hibited binding comparable to that of the monoclonal reagent,
while the commercial polyclonal reagent showed a signifi-
cant decrease in binding to purified rhILK.
To determine whether R3B1 could immunoprecipitate
ILK, we combined lysate from cultured mouse LEC with iden-
tical concentrations of either control rabbit IgG, commercial
polyclonal anti-ILK IgG, or R3B1 IgG. The resulting immu-
noprecipitates were resolved by SDS-PAGE and were
immunoblotted with the monoclonal anti-ILK antibody (Fig-
ure 1D). Both commercial and R3B1 polyclonal antibodies
immunoprecipitated ILK from mouse cell lysates, without any
cross-reactivity seen with either beads alone (Figure 1D; lane
2) or with nonspecific rabbit IgG (Figure 1D; lane 3). There-
fore, affinity-purified R3B1 showed strong reactivity with
rhILK, comparable to that of the commercial monoclonal anti-
ILK antibody. In contrast, the commercial polyclonal antibody
recognized a protein of different mass on immunoblots only
under reducing conditions and displayed less recognition of
antigen by ELISA (Figure 1C). Both commercial and R3B1
polyclonal antibodies immunoprecipitated ILK from mouse
cell lysates (Figure 1D).
ILK expression in the mouse lens:  For evaluation of ILK
expression in the mouse lens, 1-month-old eyes were dissected
into the following fractions: capsule/LEC, cortical fiber cells,
and nuclear fiber cells, the lysates of which were used for
immunoblotting. Three separate samples were probed with
R3B1 for the presence of ILK (Figure 2A). Relative to LEC,
ILK protein was increased in both cortical and nuclear fiber
cell fractions. RT-PCR was also performed on RNA isolated
from dissected lenses (LEC and fiber fractions) and two im-
mortalized LEC lines, in which one was derived from a mouse
and the other from a human (Figure 2B). LEC derived from
lens explants showed significantly less ILK mRNA than ei-
ther the fiber cell fraction or the immortalized human and
mouse LEC lines.
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Figure 2. ILK in the mouse lens and in
immortalized lens cells.  A: Western blot
of lysates from cortical and nuclear fiber
cells dissected from mouse lenses. Addi-
tional probe for GAPDH is shown as a
protein loading control. Molecular weight
markers are indicated on the left. B: RT-
PCR for ILK performed on RNA isolated
from immortalized mouse (lane 1) and
human LEC (lane 2), as well as mouse
lens tissue dissected into capsule/epithe-
lial (lane 3) and lens fiber fractions (lane
4). Probe for GAPDH mRNA is shown
as a control for cellular RNA.
710To define further the expression pattern of ILK in the lens,
we embedded whole lenses for sectioning and immunofluo-
rescence (Figure 3). A non-specific isotype control IgG, the
commercial rabbit polyclonal anti-ILK IgG, or R3B1 anti-ILK
antibodies preabsorbed with rhILK demonstrated the speci-
ficity of the R3B1 antibody (Figure 3C,E,G, respectively; see
Figure 3A for reference areas shown in Figure 3B-G). Stain-
ing of the LEC along the anterior of the lens was minimal and
appeared to be concentrated at the border of the LEC and
newly-differentiated fiber cells (Figure 3B, bright green color).
In contrast, significant staining for ILK was observed in the
differentiating LEC and fiber cells of the equatorial region
(Figure 3D, bright green color). Newly-differentiated fiber cells
were also reactive with anti-ILK IgG along the posterior edge
of the lens (Figure 3F, bright green color). The immunohis-
tochemistry in Figure 3 revealed strong reactivity for ILK at
the equatorial region and the anterior and posterior ends of
newly-differentiated fiber cells, in comparison to isotype, com-
mercial, and preabsorbed staining controls (Figure 3B-G).
These data are consistent with the detection of ILK mRNA
and protein in the cortical fibers but not in the majority of
LEC, as shown in Figure 2.
To verify the relative cellular location of ILK in the lens,
we performed simultaneous staining of ILK with either anti-
β1-integrin or anti-EEA-1 IgG (Figure 4A,B). Staining for ILK
coincided with staining for β1-integrin, i.e., along the LEC-
fiber cell interface at the equatorial region (Figure 4A). How-
ever, there was no apparent coincidence between ILK and the
endosomal marker EEA1 (Figure 4B).
Expression of ILK as a function of EMT of LEC in vitro:
As described above, the epithelial layer of the lens does not
produce high levels of ILK protein in vivo until differentia-
tion occurs. Alternatively, immortalized lens cell lines did pro-
duce ILK in vitro (Figure 2B). To resolve this apparent dis-
crepancy, we grew primary cultures from explanted mouse
lenses in culture for various times and subsequently
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Figure 3. Localization of ILK in the mouse lens.  A: Hematoxylin and eosin-stained mouse lens. The red arrow denotes the lens epithelial cell
layer. Boxes indicate anterior (B,C), equatorial (D,E), and posterior (F,G) areas imaged for immunohistochemistry. B: Immunohistochemistry
of mouse lens anterior LEC and fiber cells with affinity-purified anti-ILK IgG (R3B1). FITC-conjugated donkey anti-rabbit IgG was used as
a secondary antibody. C: Immunohistochemistry of anterior LEC with commercial polyclonal anti-ILK antibody. D: Immunohistochemistry
of lens equatorial region with R3B1. E: Immunohistochemistry of lens equatorial region with R3B1 pre-absorbed with 10 µg/ml rhILK. F:
Immunohistochemistry of the posterior lens with R3B1. G: Immunohistochemistry of the posterior lens with rabbit IgG control. The scale bar
is equal to 10 µm.
711immunoblotted lysates for ILK (Figure 5A; ILK) or α-SMA,
a marker for EMT in LEC (SMA; Figure 5A). As the cells
adapted to culture conditions over time, indicated by increased
α-SMA production, their levels of ILK increased significantly.
Within 14 days of culture, expression of α-SMA and ILK in
primary LEC became comparable to that seen in the immor-
talized LEC lines (Figure 5A, compare lanes 2 and 5). Quan-
tification of protein production during culture adaptation is
shown in (Figure 5B). To determine whether expression of
ILK was required for the increase in α-SMA seen in LEC af-
ter 14 days of culture, we cultured lens explants in the pres-
ence of control (GFP-) or ILK-targeting siRNA (Figure 5C).
In addition to the decreased levels of ILK in the explanted
cultures upon exposure to ILK-targeting siRNA, there was
concomitantly a decreased expression of the EMT protein
markers, α-SMA and fibronectin, in comparison with control
samples (Figure 5C, compare lanes 2 and 4). During extended
culture, inhibition of ILK did not stop the progression of EMT
in explant outgrowths (as measured by augmented levels of
α-SMA and fibronectin), but it did significantly retard the in-
duction of these two markers (Figure 5D). Therefore, ILK pro-
tein expression increased upon initiation of the EMT process
in vitro. When ILK was inhibited by siRNA, the EMT pro-
gression slowed significantly, the data indicating a role for
ILK in EMT of mouse LEC.
ILK expression in immortalized mouse lens epithelial
cells:  To examine ILK expression in cultured mouse LEC,
we probed lysates of resting and serum-depleted cells with
R3B1 (Figure 6A). ILK was expressed in cultured LEC and
its expression increased under the stress of serum-deprivation
(Figure 6A, compare lanes 1 and 2). In vitro kinase assays
were also performed with the commercial anti-ILK and the
affinity-purified R3B1 polyclonal antibodies, both of which
immunoprecipitated ILK from resting and serum-deprived
LEC. Purified MBP, an ILK substrate, was added to the reac-
tion after precipitation and the phosphorylated form was probed
after SDS-PAGE (Figure 6B). Commercial and R3B1
polyclonal antibodies precipitated active ILK in the kinase
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Figure 4. Coincidence of ILK with β1-
integrin but not EEA1 in the mouse lens.
A: Immunohistochemistry with R3B1
(red) and anti-β1 integrin antibody
(green). Yellow indicates coincidence of
staining (arrows). The scale bar is equal
to 1 µm. B: Immunohistochemistry with
R3B1 (green; arrows) and anti-EEA1
antibody (red; arrowheads). No coinci-
dental staining is evident. The scale bar
is equal to 10 µm. Morphological alter-
ations and non-specific staining for ILK
in the capsule (A, extreme right) occurred
with the staining protocol required for
integrin immunohistochemistry.
712assay. Serum-deprivation of cells resulted in increased phos-
phorylated MBP (MBP-P) relative to resting cells and isotype
immunoprecipitation controls.
Immunocytochemistry with R3B1 was performed on LEC
plated on glass coverslips (Figure 6C-J). Staining of ILK was
clearly evident in cultured LEC (Figure 6C) relative to the
IgG control (Figure 6D) and could be competed by prior satu-
ration of the antibody with rhILK (Figure 6E). Pre-absorption
of R3B1 with rhILK resulted in some fluorescent precipitate
that appeared across the field in a plane above the cells (ag-
gregates in Figure 6E). Colocalization of ILK with β1-integrin
was also evident in cultured LEC, with specific staining ap-
parent along the edges of cells (Figure 6F, arrows).
Colocalization of ILK with the fibronectin-binding integrin
α5β1 was also investigated on non-coated (Figure 5G) and
fibronectin-coated coverslips (Figure 6H). Coating with
fibronectin increased both the apparent levels of α5β1 integrin
and its colocalization with ILK (arrows, Figure 6H). The dis-
tribution of ILK in cultured LEC did not coincide with that of
the endosomal marker EEA1 (Figure 6I,J), a result consistent
with data from sectioned lenses (Figure 4B). Staining by R3B1
IgG was also present in resting and stressed hRPE plated on
glass coverslips (Figure 7).
LEC, therefore, produced ILK, seen as a specific band
(about 50 kDa) in immunoblotted lysates. An increase in ILK
protein synthesis was apparent in cells following stress. Both
commercial and R3B1 polyclonal antibodies were effective
in the immunoprecipitation of active ILK for in vitro kinase
assays. Staining of cultured cells showed strong reactivity and
specificity for ILK, whereas incubation with rhILK signifi-
cantly decreased intracellular staining. ILK, identified by
R3B1, colocalized with both β1-integrin and α5β1 integrin,
which was increased after the plating of cells on fibronectin-
coated coverslips. Importantly, ILK did not co-localize with
the endosomal marker EEA1. Moreover, the distribution of
ILK in LEC appeared unique in comparison with that of an-
other immortalized, ocular epithelial cell line, hRPE.
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Figure 5. ILK is induced during LEC differentiation and inhibition of ILK retards expression of EMT markers α-SMA and fibronectin.  A:
Immunoblot of lysates (20 µg/lane) from immortalized and primary mouse LEC that grew out from dissected lens capsules (0-14 days). Lane
1, rhILK (500 ng); lane 2, immortalized LEC; lane 3, primary LEC, 0 days; lane 4, primary LEC, 7 days; lane 5, primary LEC, 14 days. Lysates
were probed for ILK and α-SMA as an indicator of EMT. rhILK (lane 1) was used for protein size comparison, and a probe for GAPDH was
used to normalize protein loading. B: Densitometry of protein bands from the blot shown in A. Relative expression values are normalized to
those of GAPDH. C: Immunoblot of lysates (2 capsules/lane) from primary mouse LEC that grew out from dissected lens capsules (0-14
days). Lane 1, primary LEC + ILK-targeting siRNA, 7 days; lane 2, primary LEC + ILK-targeting siRNA, 14 days; lane 3, primary LEC +
GFP-targeting siRNA (control), 7 days; lane 4, primary LEC + GFP-targeting siRNA. Lysates were probed for ILK to verify ILK-targeting
siRNA efficiency. Fibronectin and α-SMA were monitored as indicators of EMT. An additional probe for GAPDH was used to normalize
protein loading. D: Densitometry of protein bands from the blot shown in C. ILK- and GFP-siRNA-treated explants show a significant
difference in protein expression after 14 days of culture (the asterisk indicates a p<0.02). Relative values are normalized to that of GAPDH.
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Figure 6. Production and localization of ILK in cultured mouse LEC.  A: Immunoblot of lysates (20 µg/lane) from resting (lane 1) and serum-
deprived cultured LEC (lane 2). Additional probe for GAPDH is shown as a protein loading control. Molecular weight standards are indicated
at left. B: Immunoblot of phosphorylated MBP (MBP-P) following immunoprecipitation of ILK with commercial (#06-592) or R3B1 polyclonal
antibodies, followed by in vitro kinase assay. C: Immunocytochemistry with affinity-purified anti-ILK IgG (R3B1) of LEC plated on glass
coverslips; arrows indicate ILK. FITC-conjugated donkey anti-rabbit IgG was used as a secondary antibody. D: Staining performed with
rabbit IgG control. E: Staining with R3B1 antibody preincubated with 10 mu g/ml rhILK. F: Staining with R3B1 (red) and anti-β1 integrin
antibody (green). Yellow indicates coincidence of staining (arrows). G: Staining of cells with R3B1 (red) and anti-α5β1 integrin antibody
(green). H: Staining with R3B1 (red) and anti-α5β1 integrin antibody (green) of cells plated on glass coverslips coated with 10 µg/ml fibronectin.
Arrows in G and H indicate coincidence of staining. I-J: Staining with R3B1 (red) and anti-EEA1 antibody (green). Arrows indicate ILK;
arrowheads indicate EEA1. The scale bar is equal to 1 µm.
714DISCUSSION
 ILK functions in several diverse biological processes includ-
ing cellular proliferation, survival, motility, and differentia-
tion. In animal models ILK has been shown to have important
activities in tumor growth/progression, angiogenesis, and tis-
sue differentiation. However, little is known about the func-
tion of ILK in the mammalian eye, specifically in the lens.
The specialized functions required of the lens epithelial layer
for lens maturation and continued transparency make subsets
of these cells prime candidates for the expression of ILK. In
addition, LEC plays an important role in the potential devel-
opment of PCO after cataract surgery, a process entailing EMT
[19]. For these reasons we explored the expression and role of
ILK in the mouse lens and during EMT of lens cells in vitro. It
was first necessary, however, to produce and characterize a
new anti-ILK antibody.
Previous studies on ILK have been performed with com-
mercially-available reagents that have varied reactivity against
ILK and identify proteins with different molecular masses (or
possibly, different proteins). Production of an affinity-puri-
fied, polyclonal antibody against rhILK (R3B1) proved an ef-
fective solution to the variability of available reagents. R3B1
IgG performed reproducibly for immunoblotting, immunopre-
cipitation, and immunohisto/cytochemistry under different pro-
tocols of fixation and staining. The purified antibody recog-
nized a band on SDS-PAGE of 50 kDa after reduction and
was reactive in ELISA with sensitivity similar to that of the
available monoclonal reagent. Staining with the antibody
showed specific reactivity in tissue and cells that could be
competed by pre-incubation of the antibody with rhILK. Re-
sults from immunoblotting, immunocytochemistry, and im-
munohistochemistry with R3B1 have been comparable to those
with the monoclonal antibody [5,20,21]. However, the mono-
clonal antibody has not been verified for immunoprecipita-
tion of ILK. We therefore demonstrate the purification of a
polyclonal anti-ILK antibody with the specificity and reactiv-
ity of a commercially-available monoclonal antibody. The
polyclonal R3B1 was effective in immunoprecipitation,
immunostaining, and in vitro kinase assays.
While the presence of ILK in the mouse lens was expected,
expression was surprisingly localized to the differentiating
LEC of the equatorial region and to fiber cells, with little to
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Figure 7. Localization and increased production of ILK in cultured human RPE.  Immunocytochemistry with affinity-purified anti-ILK IgG
(R3B1) of hRPE plated on glass coverslips. FITC-conjugated donkey anti-rabbit IgG was used as a secondary antibody. A: Non-stressed hRPE
stained with R3B1 (green). B: hRPE deprived of serum for 24 h and subsequently stained with R3B1 (green). Increased ILK expression was
apparent after stress. Arrows indicate localized ILK staining in hRPE. The scale bar is equal to 1 µm.
715no expression in the anterior LEC layer. These data were con-
firmed by immunoblot of dissected lens fractions. Results from
RT-PCR were also consistent with data derived from
immunoblots, which illustrated the low levels of ILK mRNA
present in isolated LEC that increased after differentiation of
LEC into fiber cells. Levels of ILK were also substantial in
two immortalized lens cell lines.
Immunohistochemistry was subsequently performed on
the lens to verify specific localization of ILK in differentiat-
ing LEC and fiber cells. Staining revealed a concentration of
ILK along the interface marking the posterior edge of the equa-
torial LEC and anterior ends of newly-differentiated fiber cells.
Staining for ILK continued posterior to the equatorial region
along the lateral membranes of the most recently-differenti-
ated fiber cells. Significant levels of ILK were also observed
at the lens anterior surface, apparently localized along fiber
cell membranes. Immunostaining for ILK and β1-integrin
showed coincidence at the LEC-fiber cell interface, anterior
to the equatorial region of the lens. The localization of ILK
deposits in the lens coincides with immunohistochemistry
performed in the developing murine brain that revealed foci
of ILK at the interface between differentiating tissue layers in
a membrane-associated pattern [5].
ILK, with its known association with the cytoplasmic tails
of integrin β1- and β3-subunits, would be expected to function
optimally at integrin-localized areas. Previous work has shown
a distribution of β1-integrin, unique among tissue epithelia, at
both basal and apical membranes of LEC and differentiating
fiber cells [22,23]. Of specific interest are the alterations in
integrins required during the differentiation of LEC and sub-
sequent fiber cell elongation, migration, and survival. Fiber
cell maturation requires migration along the anterior of the
lens where little to no ECM is deposited. Additionally, these
cells must survive a modified apoptotic process resulting in
denucleation, elimination of most organelles, and significant
cytoskeletal alterations (reviewed in [24]). The interface be-
tween LEC and fiber cells has been shown to be a site of chang-
ing integrin interactions and expression by newly-differenti-
ated fiber cells (reviewed in [25]). Of note are alterations ob-
served in the α6-integrin subunit, a binding partner of β1-
integrin. α6-integrin expression, cytoskeletal interaction, and
anti-apoptotic signaling are upregulated in LEC as they enter
the equatorial region, and these changes continue during fiber
cell differentiation, even in a microenvironment (the LEC-fi-
ber cell interface) which exhibits a paucity of ECM deposi-
tion [26-29]. Specifically in the lens fiber cells, α6-integrin
has been shown to stimulate PI3K-dependent signaling, which
regulates cytoskeletal reorganization and survival during the
process of denucleation [29]. Downstream of PI3K/AKT sig-
naling, inhibition of GSK-3β has been postulated to act as a
survival mechanism during lens differentiation [29]. In addi-
tion to the PI3K pathway, GSK-3b can be directly inhibited
by ILK phosphorylation in a PI3K-dependent manner (re-
viewed in [1]). As ILK has been previously shown to be in-
volved in cell survival and cytoskeletal alteration, we postu-
late that the unexpected distribution of ILK in the lens is due
in part to the lens-specific expression pattern of its known
interacting integrin partners. This localization would allow ILK
to function as a positive regulator of cytoskeletal alteration,
migration, and survival in LEC and fiber cells during differ-
entiation in the lens.
Despite little to no protein detected by either
immunoblotting or immunohistochemistry, the dissected LEC
fraction contained ILK mRNA. It is possible that contamina-
tion of LEC or fiber cells during dissection, or the inclusion
of cells from the equatorial region, could account for the faint
ILK mRNA signal in the LEC fraction. Whereas ILK expres-
sion by LEC in vivo appears minimal, it is upregulated during
their differentiation into fiber cells. As ILK has been impli-
cated in EMT [12-14] and is expressed by most cultured cells
(reviewed in [1]), we proceeded to determine the expression
pattern of ILK and its potential role during culture of explanted
LEC.
The process of EMT in LEC has been seen during the
adaptation of lens cells to culture conditions and as a result of
cataract surgery, as LEC escaping surgical removal regrow on
the posterior surface of the lens implant. These changes in-
clude the increased production of survival factors and changes
in cytoskeletal and integrin proteins [11]. We investigated the
role of ILK in this adaptation process by characterizing im-
mortalized LEC and primary LEC outgrowths from lens ex-
plants. Over a 2 week interval, immunoblotting and staining
showed strong ILK expression in the cell lines and increased
levels of ILK in primary mouse LEC. The production of ILK
by the explanted LEC was increased concomitantly with that
of the EMT markers, α-SMA and fibronectin. Similar results
were obtained with regard to ILK and the EMT process in
renal tubular epithelial cells [12,14]. ILK-targeting siRNAs
were next used to inhibit ILK expression during EMT of the
explant cultures. siRNA transfection eliminated the majority
of ILK expression (about 70%) over the explant culture pe-
riod (14 days). This inhibition of ILK production was associ-
ated with a retardation of EMT progression, as indicated by
the reduced levels of α-SMA and fibronectin. These results
substantiate the proposed role for ILK as a positive regulator
during LEC EMT and as a target for retardation of PCO fol-
lowing cataract surgery [11].
In immortalized LEC, ILK could also be induced by stress
in the form of serum deprivation. The removal of serum led to
an increase in protein expression and ILK kinase activity, as
verified by phosphorylation of its target MBP. ILK was local-
ized in cultured LEC in a distinctive pattern resembling that
of certain cytoplasmic proteins including tubulin, lens-spe-
cific microtubules, and some of the actin-associated proteins.
Although increases in ILK protein were evident in both LEC
and cultured hRPE after stress (Figure 6A and Figure 7), a
similar pattern of ILK localization was not observed in cul-
tured hRPE (compare Figure 6C and Figure 7). It is, there-
fore, possible that EMT-mediated localization of ILK occurs
in cultured LEC. Enhanced production of specific EMT-in-
duced cytoskeletal proteins could potentiate ILK binding and
ILK-induced motility, as has been previously reported for cul-
tured myocytes [21]. Work is ongoing to identify EMT-asso-
ciated and/or lens-specific cytoskeletal components that could
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716account for the staining pattern observed for ILK in cultured
LEC. As expected, coincident staining of ILK and β1 integrin,
as well as the α5β1 complex, was observed in cultured LEC.
Moreover, colocalization was enhanced after α5β1 integrin was
activated by its preferred ECM ligand, fibronectin.
The use of a novel anti-ILK antibody has allowed us to
identify ILK in the newly-differentiated fiber cells of the mouse
lens. Although there do not appear to be substantial amounts
of ILK mRNA or protein in the anterior lens epithelia, there is
an increase in expression as LEC enter the equatorial region
of the lens and begin differentiation into fiber cells, a result
consistent with recently published data [30]. In addition, ILK
production in LEC significantly increased as these cells were
grown in vitro, data lending credence to the hypothesis that
ILK plays a role in LEC EMT and potentially in the PCO
process that can occur after cataract surgery.
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